chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I am a 61 year old female, who had been in good health prior to taking the Covid Vaccines, I have no history of ANY auto immune disease in my medical history or in my family history.    After taking my last Covid Booster in Nov. of 2021, I began to experience EXTREME fatigue, hair loss, loss of memory and TERRIBLE pain and swelling in my fingers and legs.    I saw my Primary doctor in May 2022, when my symptoms were VERY severe.  My PCP, suggested that I be tested for Lupus, and I asked to be tested for RA since I had so much joint pain and swelling.
Neck: normal, supple, no lymphadenopathy, no meningeal signs.  Respiratory exam: normal, no intercostal retractions, movements symmetrical, no wheezes or rhonchi.  Heart exam: normal, pink, no thrill or palpable murmurs, no displacement of PMI, S1, S2, no murmur, rub, or gallop.  Abdomen: normal, benign, no masses, bowel sounds normal.  Skin exam: see above.  Morbilliform rash on trunk>extremities>face, but diffuse, symmetric.  Not rough, no hives.  Minor diagnosis of viral exanthema: enteroviral-like, but wrong season.  D/W mom.  Observe.  Mom advised to call if symptoms worsen, fail to improve, or new symptoms develop.  R/o vaccine reaction: VAERS form completed.
Sudden onset of moderate sharp pain shooting into his right side of the neck; Sudden onset of moderate sharp pain shooting into his right side of the neck in to his ear; Mononeuropathy; This case was reported by a lawyer and described the occurrence of mononeuropathy in a 54-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 19th August 2020, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 27th August 2020, 8 days after receiving Shingrix, the patient experienced mononeuropathy (serious criteria GSK medically significant). On an unknown date, the patient experienced neck pain and ear pain. The action taken with Shingrix was unknown. On an unknown date, the outcome of the mononeuropathy, neck pain and ear pain were unknown.   It was unknown if the reporter considered the mononeuropathy, neck pain and ear pain to be related to Shingrix.  Initial information received via legal complaint on 27 May 2021.The patient received 1st dose of Shingrix on 19 August 2020. The patient experienced sudden onset of moderate sharp pain shooting into his right side of the neck in to his ear as well as multiple places of moderate after taking shingrix vaccination. On 27 August 2020 the patient experienced mononeuropathy.
severe shaking convulsive; chills; nausea; leg cramps; difficulty breathing; vomitting; This is a spontaneous report from a contactable consumer (patient). A 65-year-old male patient received single dose of BNT162B2 (PFIZER, Solution for injection, batch/lot number and exp date not reported ), via an unspecified route of administration (vaccine location: left arm) on 22Jan2021 10:45 for COVID-19 immunization. Medical history included diabetes and high cholesterol. The patient did not have Covid prior vaccination. The patient had no known allergies. Concomitant medication/other medications within two weeks included rosuvastatin calcium (CRESTOR), telmisartan, empagliflozin, metformin hydrochloride (SYNJARDY), and atenolol. There was no other vaccine within four weeks. On 24Jan2021 02:00, the patient experienced severe shaking convulsive, chills, nausea, leg cramps, difficulty breathing, and vomiting. No treatment was received for the events. The patient was not Covid tested post vaccination. The patient recovered from the events on an unspecified date in Jan2021.  Information about lot number and expiry date for the suspect product will be requested in follow-up attempts.
accidental overdose is reported in a pt receiving fluogen; pt has a hx of alzheimer's disease;
Presented to the ER with increasing SOB and nonproductive cough.  Improved and was able to discharge home with portable O2 on  1/4/2022.
Patient received 2nd dose of Moderna vaccine today  and complained of "chest tightness" and pain on left side. Patient denied SOB, also no dizziness or lightheadedness/ faintness. Vitals were taken and were stable after the 2nd dose was administered. Dr. said if she felt ok and did not appear to be in distress that she could leave. Recommendation: Patient was told to contact the office if she experienced anymore side effects within the next several days.
Period started day of the shot (Sat), heavier and more cramping than usual, 1 week earlier than expected which is unusual (was not stressed leading up to appt) Fever starting Saturday night, as high as 103, dropped down to 100 at the end of the second day, still ongoing Headache Sunday and Monday Soreness on Saturday, mostly went away on Sunday, but I spent a lot of time swinging my arm around
AFTER ABOUT 1 MINUTE, PATIENT FAINTED, SWEATED PROFUSELY, LIPS TURNED WHITE
The pt experienced shortness of breath, difficulty breathing, weakness, passed out, very shaky and dizziness. Fast heart beat, have very scary feeling throughout whole body. Was in ER from 6:30 - 11:00 PM.
arm was swollen and red and that hurt; she cannot use her arm; eyes became blood shot; high fever; Initial information received on 13-Dec-2019 regarding an unsolicited valid non-serious case from a pharmacist.  This case involves a 65 years old female patient who experienced swollen and red arm and that hurt ((inflammation), eyes became blood shot (ocular hyperaemia), high fever (pyrexia) and she cannot use her arm (mobility decreased), while she received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE].  Medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 11-Dec-2019, the patient received a 0.5 ml dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE lot UJ307AA expiry date: 29-Jun-2020 via unknown route in the right deltoid.  On 11-Dec-2019, the patient developed a non-serious swollen and red arm, that hurt (inflammation), eyes became blood shot (ocular hyperaemia), high fever (pyrexia) and she cannot use her arm (mobility decreased) same day following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE.  Laboratory details were not reported.  Final diagnosis was inflammation, ocular hyperaemia pyrexia and mobility decreased.   It was not reported if the patient received a corrective treatment.  The event outcome was reported as unknown for inflammation, ocular hyperaemia pyrexia and mobility decreased.
Sore arm; almost a feeling like you get a panic attack exact, that kind of feeling; she would eat; she still have that empty feeling in her stomach, felt like, almost if, she didn''t eat up felt that hunger even she ate; she said she felt almost like, somebody was pushing on her stomach, and then letting down like a weird feeling; flu like symptoms after the vaccine; she get chest pain; This is a spontaneous report from a contactable consumer or other non-Health Care Professional via  Support. A 21-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiry date: Unknown), dose 1 via an unspecified route of administration on 11Sep2021 as DOSE 1, SINGLE for Covid-19 immunization. The patient medical history was not reported.The patient's concomitant medications were not reported.On an unspecified date the patient experienced sore arm , almost a feeling like you get a panic attack exact, that kind of feeling, she would eat; she still have that empty feeling in her stomach, felt like, almost if, she didn't eat up felt that hunger even she ate, she said she felt almost like, somebody was pushing on her stomach, and then letting down like a weird feeling, flu like symptoms after the vaccine, she get chest pain.The outcome of event was unknown.  The lot number for BNT162B2 was not provided and will be request during follow-up.
Rash/welt, 1.5 inch at injection site, itching and painful.  Larger area around center welt, also itching.
Sore arm; Itchy feets; Itchy hands; This is a spontaneous report from a non-contactable consumer, the patient. A 51-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6199) via an unspecified route of administration in the arm left on 24Mar2021 at 09:15 (at the age of 51-years-old) as a single dose for COVID-19 immunisation.  Medical history was not reported. The patient had no known allergy. Concomitant medications included ibuprofen sodium (MANUFACTURER UNKNOWN) started on an unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Mar2021 at 10:30 the patient experienced sore arm, for 36 hours after vaccine, itchy hands and feet 1 hour after vaccine that lasted 1 hour and the same irritation occurred the second morning after the vaccine for about 2 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event sore arm resolved on 26Mar2021 at 22:30 and that of events itchy feet and itchy hands was resolved with sequelae on 24Mar2021.  No follow-up attempts are needed. No further information is expected.
Immediately after receiving the vaccine I had a metallic taste in my mouth. This lasted for 20 hours.
On 2/12/201: the night prior, woke up many times during the night; at daycare, was sleepy and did not want to bear weight and had to hold onto someone to walk; was sent to hospital.  Vital signs  were normal, was given apple juice to drink and perked up. Stayed for observation for 2 hours, ate applesauce  and was discharged home. Symptoms have resolved and was checked in the office today 2/15/2021 and was fine.
On 09/05/2000, the patient developed chickenpox. Follow up information from a physician indicated that on 09/15/2000 the patient fully recovered.
Pt reports that she has had well controlled hypertension for years, has never had any problems with high readings, but a couple weeks after her vaccination she is having consistently elevated readings.  Both her and her boyfriend are having the same reaction and want it reported, as this is consistent to what they, "read on the internet."  Is going to follow up with pcp.
Pt called on 10/12 to report pain at the injection site since she was given the shot on 10/11. She felt like the shot was given too high on her shoulder. She said it has been continuous pain and has taken tylenol and used topicals for the pain.
Tdap RD in afternoon. During leveling arm became sore. Went to work 6/14/13 symptoms of arm pain, swelling, fever 103.5, sore throat "flu-like" symptoms, that progressed during day. Felt ill for several days. Just beginning to feel better today (6/17/13)".
*SPORADIC*  Light headedness, difficulty breathing, racing heart. Sporadically throughout the day/ night. Not related to physical activity. Lasts from 10-30 minutes.
Patient arrived today to receive Janssen COVID-19 vaccine. While providing the patient with education about the vaccine the patient stated "I have a history of passing out when I get IV's and blood work done." Patient voiced that they would like to proceed with the Janssen COVID-19 vaccine today. After receiving the vaccine the patient stated that they were feeling fine, but would like to stay seated before moving to the designated waiting area. Upon observation by this nurse one minute later the patient was starting to look flushed, and the patient stated "I am starting to feel dizzy and sweaty." This nurse stayed close to patient and provided fanning. The patient stated that they would like to sit on the floor. The patient sat on the floor and then proceeded to lay down as the patient stated " laying down helps with the dizziness." This nurse obtained vital signs and ask for a co-worker to provide the patient with water. This nurse stayed with the patient and kept up a conversation while the patient waited the recommended time of 15 minutes after getting a vaccine. The patient never lost level of consciousness which was assessed by the patient kept talking with staff. Before the 15 minutes was up the patient voiced that they were feeling better. Upon assessment before leaving the patient was no longer sweating and no longer had the flushed skin appearance. The patient was able to stand and walk without assistance, and no abnormalities were observed.
Severe Nausea, no other symptoms. Escorted pt to the ER for further evaluation.
sore arm; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of pain in extremity (received 1st dose on an unknown date, for tolerance refer case US2022AMR004592).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain in arm. Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.     Linked case(s) involving the same patient:  US2022AMR004592  Additional details were reported as follows: The patient self-reported this case. The age at vaccination was not reported. The patient had a sore arm for a day or two with each of the two shots. The follow-up would not be possible as no contact details were available.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR004601:same reporter - other patient
Initial report received from a non-health care professional on 04 March 2013. A female patient of unknown age, had received an intramuscular dose of ADACEL vaccine (lot number, expiry date, dose number and site of vaccination was not reported) on an unspecified date. On an unspecified date, hours after vaccination, the patient developed muscle aches on the left side of the body and beginning in neck. The patient also had a "shock" feeling that goes throughout her body. Muscle aches had spread to shoulders and legs bilaterally. Corrective treatment was not reported. Laboratory investigations were not done. Patient was seen by a neurologist, nothing significant was found. The "shock" feelings had subsided, but the muscle aches were progressively becoming worse. Documents held by sender: none.
felt like someone was taking a knife to his back; water build up in legs; Migraine; Cough; swelling of the throat; stuffy nose; temperature of 104.3F; small rash on left leg; right arm went numb/ both legs went numb/ back went numb; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (right arm went numb/ both legs went numb/ back went numb), BACK PAIN (felt like someone was taking a knife to his back), FLUID RETENTION (water build up in legs), MIGRAINE (Migraine) and COUGH (Cough) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033C21A and 023C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HYPOAESTHESIA (right arm went numb/ both legs went numb/ back went numb). On 03-Jun-2021, the patient experienced RASH (small rash on left leg). On an unknown date, the patient experienced BACK PAIN (felt like someone was taking a knife to his back), FLUID RETENTION (water build up in legs), MIGRAINE (Migraine), COUGH (Cough), PHARYNGEAL SWELLING (swelling of the throat), NASAL CONGESTION (stuffy nose) and PYREXIA (temperature of 104.3F). At the time of the report, HYPOAESTHESIA (right arm went numb/ both legs went numb/ back went numb), BACK PAIN (felt like someone was taking a knife to his back), FLUID RETENTION (water build up in legs), MIGRAINE (Migraine), COUGH (Cough), PHARYNGEAL SWELLING (swelling of the throat), NASAL CONGESTION (stuffy nose), RASH (small rash on left leg) and PYREXIA (temperature of 104.3F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 104.3 (High) 104.3 F.     No concomitant medication was reported. Treatment medication was not provided. Action taken with mRNA-1273 in response to the event was not applicable.
Pt came to pharmacy 2 days after being vaccinated. His arm was red and warm around the area he got the shot and he also complained of soreness at vaccination site and extending to his back. I advised him to go the hospital to rule out an infection and to keep us updated. The pt did not go to the hospital until 2/19/2017. The pt's sister called us on 2/20/17 to let us know that they were told the pt had an allergic reaction to one of the components of the PREVNAR 13 vaccine.
no adverse effect; multiple patients were vaccinated with improperly stored VAQTA on multiple dates; This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 03-DEC-2018, the patient was vaccinated with improperly stored hepatitis a vaccine, inactivated(VAQTA) lot # R006209, expiry date 16-MAR-2019 for prophylaxis.  No adverse event was reported. Previous temperature excursion was reported. Data logger was involved.
After 2nd shot of the Moderna I had intermittent ear ringing. A week after the 2nd shot it became a constant ring.  High pitch constant ringing. Tinnitus.
Upon entering in vaccination administration data in to the Immunization Information System website, it was noted that patient received COVID PFR booster on 1/21/22.
Patient fainted within 1 minute of receiving the vaccine.  Patient was sitting down at the time so she did not hit the ground.  Her head tilted backward and hit the computer keyboard (but not hard).  Patient awoke within 30 seconds.   Patient was laid down for approximately 10 minutes.  Patient was alert, conscious, aware of her situation.  After ten minutes she was completely back to normal and was able to leave 10 minutes after that on her own power with no problems.
Pt received vaccine at 12:40 pm. Pt works in clinic and alerted another nurse at  2:00 pm of possible allergic reaction.  Face flushed, breathing rapidly, itching at chest. Pt reported nausea with dry heaving. Pt was placed in a room with fan for air circulation, v/s obtained. PCP notified, pt was given benadryl 50mg IM and Zofran 4mg orally. Pt continuously monitored. At 2:36 pm pt symptoms improving, v/s WNL, provider notifed, pt released.
a few hours after injection (which was on a Wednesday), pt started to get a sore arm. then started to get fatigue which got progressively worse over the next several days.  pt started having body aches 2 days after vaccine.  by friday pt had sob also. on sunday, pt had an episode of severe fatigue and heart palpitations. by sunday night, she was feeling better.
pt recv vax;in eve,stated flu-like sx & HA which inc in severity over next 2-3 days; T 104,aches,acute upper abd pain;tingling,numbness in legs,fatigue,weakness,anorexia;seen by PMD;dx as hypersensitivity rxn;WBC=3.5;chloride=110;
SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19; METALLIC TASTE IN THE MOUTH; DIARRHEA; This spontaneous report received from a patient via other company (Pfizer) concerned a patient of unspecified age, sex, race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: anemia, anxiety disorder, and penicillin allergy. On 16-MAR-2021, the patient received covid-19 vaccine ad26.cov2.s (dose number in series: 1) (suspension for injection, route of admin, and batch number were not reported, expiry: unknown) dose was not reported, 1 total administered to right arm for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. On 29-OCT-2021, the patient received non-company suspect vaccine tozinameran (Pfizer BioNTech vaccine) (dose number in series: 2) (form of admin, route of admin, and batch number were not reported, expiry: unknown) dose was not reported, administered to right arm for prophylactic vaccination. Concomitant medications included lorazepam. On an unspecified date, the patient experienced covid-19 (coded as suspected covid-19) (dose number in series: 2) which indicated suspected clinical vaccination failure (dose number in series: 1). On 12-MAY-2022, the patient was prescribed with non-company suspect drug Paxlovid (batch number: Fy7031) dose and frequency were not reported for covid-19. On 13-MAY-2022, the patient experienced metallic taste in the mouth, and diarrhea (dose number in series: 2). On an unspecified date in MAY-2022, the patient took the last dose of Paxlovid. The action taken with covid-19 vaccine ad26.cov2.s, and tozinameran was not applicable. The patient was recovering from metallic taste in the mouth, and diarrhea, and the outcome of suspected covid-19 and suspected clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with a product quality complaint and reference number was requested.; Sender's Comments: V0- 20220541580 -COVID-19 VACCINE Ad26.COV2.S- Suspected Clinical Vaccination failure- The event(s) has a unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS. Therefore, this event(s) is considered not related.
Started with Chills, low-grade fever and tired.  I took nothing and slept.  It lasted from Saturday night, March 20th, to March 23rd of 2021.
Walking to the car after the fifteen minute wait, I started having problems with blur in my left eye.  The blur continued through the week.  On Thursday, June 17th, I went to the emergency room.  I was seeing black blurs throughout my vision in my left eye (as though black ink was spilled into a glass of water).  The next day, when being examined by a specialist, I started seeing spots of white light in the lower left and far left of my left eye.  I saw a second specialist on June 30th who diagnosed that I had had a vitreous detachment of my left eye.
Information has been received from a medical assistant referring to an adolescent patient of unknown age and gender. Concurrent conditions, medical history and concomitant medications were not reported. On 23-SEP-2015, the patient was vaccinated with second dose of improperly stored VAQTA, lot # L018499; expiry: 25-FEB-2017 (dose, route and frequency unspecified). No adverse effect was reported. This is one several reports received from the same source. Additional information has been requested.
4 days s/p immun rash on stomach & thigh about week;temp 104 highest off & on for about 4 days;
temp to 105 that noc p/receiving immun; MOM treated w/Pediaporfen & APAP w/good results;